Oncotarget

Corrections:

Correction: MiR-451 as a new tumor marker for gastric cancer

PDF  |  How to cite

Oncotarget. 2019; 10:6396-6396. https://doi.org/10.18632/oncotarget.27291

Metrics: PDF 649 views  |   ?  

Yong Shen1,2, Jiao-Mei Gong3, Li-Li Zhou4 and Jia-He Sheng2

1 Department of Pathology and Pathophysiology, Medical School of Southeast University, Nanjing, Jiangsu, China
2 Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China
3 Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
4 Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China

Published: October 29, 2019

This article has been corrected: The authors' affiliation information was listed incorrectly. The proper affiliations are as follows:

1 Department of Pathology and Pathophysiology, Medical School of Southeast University, Nanjing, Jiangsu, China
2 Department of Clinical Laboratory, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China
3 Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
4 Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China

Original article: Oncotarget. 2017; 8:56542–56545. DOI: https://doi.org/10.18632/oncotarget.17239.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27291